Pasithea Therapeutics Corp
(KTTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,914 | 33,088 | 42,398 | 47,940 | 50,321 |
| Receivables | 16 | N/A | N/A | N/A | N/A |
| Other current assets | 348 | 426 | 866 | 80 | 0 |
| TOTAL | $31,113 | $34,077 | $44,469 | $48,614 | $50,950 |
| Non-Current Assets | |||||
| PPE Net | 175 | 125 | 341 | 170 | 129 |
| Intangibles | 9,677 | 9,834 | 3,866 | 3,834 | 0 |
| Other Non-Current Assets | 1,080 | 1,144 | 932 | 410 | 0 |
| TOTAL | $10,932 | $11,103 | $5,139 | $4,413 | $129 |
| Total Assets | $42,045 | $45,180 | $49,608 | $53,028 | $51,079 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,448 | 1,481 | 1,256 | 849 | 434 |
| TOTAL | $2,122 | $1,878 | $1,514 | $950 | $434 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 788 | 804 | 1,306 | 604 | 668 |
| TOTAL | $788 | $804 | $1,306 | $604 | $668 |
| Total Liabilities | $2,910 | $2,682 | $2,820 | $1,554 | $1,101 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,306 | 1,306 | 1,462 | 1,335 | 1,164 |
| Common Shares | 18 | 0 | 18 | 18 | 18 |
| Retained earnings | -22,895 | -19,357 | -11,033 | -6,447 | -3,789 |
| Other shareholders' equity | -3 | -1 | -147 | -64 | -15 |
| TOTAL | $39,135 | $42,498 | $46,789 | $51,474 | $49,977 |
| Total Liabilities And Equity | $42,045 | $45,180 | $49,608 | $53,028 | $51,079 |